HEADER IMMUNE SYSTEM 24-APR-20 6WOL TITLE NEXT GENERATION MONOMERIC IGG4 FC BOUND TO NEONATAL FC RECEPTOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: IMMUNOGLOBULIN HEAVY CONSTANT GAMMA 4; COMPND 3 CHAIN: H; COMPND 4 FRAGMENT: DOMAINS CH3 AND CH4; COMPND 5 SYNONYM: IG GAMMA-4 CHAIN C REGION; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: IGG RECEPTOR FCRN LARGE SUBUNIT P51; COMPND 10 CHAIN: A; COMPND 11 FRAGMENT: EXTRACELLULAR DOMAIN; COMPND 12 SYNONYM: FCRN, IGG FC FRAGMENT RECEPTOR TRANSPORTER ALPHA CHAIN, COMPND 13 NEONATAL FC RECEPTOR; COMPND 14 ENGINEERED: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 17 CHAIN: B; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IGHG4; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: FCGRT, FCRN; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_COMMON: HUMAN; SOURCE 18 ORGANISM_TAXID: 9606; SOURCE 19 GENE: B2M, CDABP0092, HDCMA22P; SOURCE 20 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS ANTIBODY CONSTANT REGION, FRAGMENT CRYSTALLIZABLE, MUTATED, IMMUNE KEYWDS 2 SYSTEM, NEONATAL FC RECEPTOR EXPDTA X-RAY DIFFRACTION AUTHOR V.Y.OGANESYAN,L.SHAN,N.VAN DYK,W.F.DALL'ACQUA REVDAT 3 18-OCT-23 6WOL 1 REMARK REVDAT 2 22-SEP-21 6WOL 1 JRNL REVDAT 1 15-SEP-21 6WOL 0 JRNL AUTH L.SHAN,N.V.DYK,N.HASKINS,K.M.COOK,K.L.ROSENTHAL,R.MAZOR, JRNL AUTH 2 S.DRAGULIN-OTTO,Y.JIANG,H.WU,W.F.DALL'ACQUA,M.J.BORROK, JRNL AUTH 3 M.M.DAMSCHRODER,V.OGANESYAN JRNL TITL IN VIVO PHARMACOKINETIC ENHANCEMENT OF MONOMERIC FC AND JRNL TITL 2 MONOVALENT BISPECIFIC DESIGNS THROUGH STRUCTURAL GUIDANCE. JRNL REF COMMUN BIOL V. 4 1048 2021 JRNL REFN ESSN 2399-3642 JRNL PMID 34497355 JRNL DOI 10.1038/S42003-021-02565-5 REMARK 2 REMARK 2 RESOLUTION. 2.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 25263 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.235 REMARK 3 R VALUE (WORKING SET) : 0.234 REMARK 3 FREE R VALUE : 0.270 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1032 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.49 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.56 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1658 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.92 REMARK 3 BIN R VALUE (WORKING SET) : 0.3640 REMARK 3 BIN FREE R VALUE SET COUNT : 73 REMARK 3 BIN FREE R VALUE : 0.4190 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4576 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 99 REMARK 3 SOLVENT ATOMS : 33 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 45.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.35 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.95000 REMARK 3 B22 (A**2) : 5.10000 REMARK 3 B33 (A**2) : -2.15000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.508 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.295 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.244 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.398 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.915 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.882 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4819 ; 0.005 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 4270 ; 0.002 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6560 ; 1.425 ; 1.679 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9997 ; 1.112 ; 1.601 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 569 ; 7.851 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 248 ;34.964 ;22.782 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 781 ;17.377 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 25 ;18.227 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 613 ; 0.054 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5301 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1007 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6WOL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-APR-20. REMARK 100 THE DEPOSITION ID IS D_1000248735. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JUN-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97946 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 300K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26347 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.490 REMARK 200 RESOLUTION RANGE LOW (A) : 36.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.20300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.49 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.60 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.84700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 5HVW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.86 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M MAGNESIUM CHLORIDE HEXAHYDRATE, REMARK 280 1 M SODIUM IODIDE, 0.1 M MES, PH 6 AND 20% PEG 6000 AT A PROTEIN REMARK 280 CONCENTRATION OF 6.35 MG/ML, VAPOR DIFFUSION, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 89.22800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 89.22800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 34.14200 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 61.29900 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 34.14200 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 61.29900 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 89.22800 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 34.14200 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 61.29900 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 89.22800 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 34.14200 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 61.29900 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6570 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29750 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1 REMARK 465 GLU A 2 REMARK 465 SER A 3 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP H 270 92.64 -160.45 REMARK 500 PRO H 271 -124.28 -59.90 REMARK 500 GLU H 272 45.62 71.28 REMARK 500 ASN H 325 148.55 -174.12 REMARK 500 PRO H 329 -72.87 -61.96 REMARK 500 GLU H 357 32.87 177.59 REMARK 500 MET H 358 45.84 -140.80 REMARK 500 PRO H 374 -165.54 -73.98 REMARK 500 TYR H 434 17.39 58.15 REMARK 500 ASN A 55 86.37 -57.97 REMARK 500 LYS A 85 -75.09 61.84 REMARK 500 ASP A 101 56.71 99.25 REMARK 500 GLU A 116 132.31 -38.15 REMARK 500 PHE A 117 -17.57 -145.92 REMARK 500 GLN A 143 55.72 -90.61 REMARK 500 ASP A 145 86.82 -60.12 REMARK 500 PHE A 157 -64.48 -107.45 REMARK 500 ARG A 171 122.00 -36.94 REMARK 500 SER A 189 -116.97 -112.04 REMARK 500 SER A 202 79.98 21.35 REMARK 500 ASP A 225 152.21 157.33 REMARK 500 PHE A 226 142.90 -170.84 REMARK 500 LEU B 54 106.61 -49.11 REMARK 500 TRP B 60 -9.37 80.19 REMARK 500 THR B 73 -161.31 -108.95 REMARK 500 REMARK 500 REMARK: NULL DBREF 6WOL H 237 445 UNP P01861 IGHG4_HUMAN 117 326 DBREF 6WOL A 1 267 UNP P55899 FCGRN_HUMAN 24 290 DBREF 6WOL B 1 99 UNP P61769 B2MG_HUMAN 21 119 SEQADV 6WOL PHE H 351 UNP P01861 LEU 231 ENGINEERED MUTATION SEQADV 6WOL GLU H 354 UNP P01861 SER 234 ENGINEERED MUTATION SEQADV 6WOL ARG H 366 UNP P01861 THR 246 ENGINEERED MUTATION SEQADV 6WOL LYS H 395 UNP P01861 PRO 275 ENGINEERED MUTATION SEQADV 6WOL ARG H 405 UNP P01861 PHE 285 ENGINEERED MUTATION SEQADV 6WOL GLU H 407 UNP P01861 TYR 287 ENGINEERED MUTATION SEQADV 6WOL CYS H 432 UNP P01861 LEU 312 ENGINEERED MUTATION SEQADV 6WOL SER H 433 UNP P01861 HIS 313 ENGINEERED MUTATION SEQADV 6WOL TYR H 434 UNP P01861 ASN 314 ENGINEERED MUTATION SEQADV 6WOL LEU H 436 UNP P01861 TYR 316 ENGINEERED MUTATION SEQADV 6WOL CYS H 437 UNP P01861 THR 317 ENGINEERED MUTATION SEQADV 6WOL H UNP P01861 GLN 318 DELETION SEQRES 1 H 209 GLY PRO SER VAL PHE LEU PHE PRO PRO LYS PRO LYS ASP SEQRES 2 H 209 THR LEU MET ILE SER ARG THR PRO GLU VAL THR CYS VAL SEQRES 3 H 209 VAL VAL ASP VAL SER GLN GLU ASP PRO GLU VAL GLN PHE SEQRES 4 H 209 ASN TRP TYR VAL ASP GLY VAL GLU VAL HIS ASN ALA LYS SEQRES 5 H 209 THR LYS PRO ARG GLU GLU GLN PHE ASN SER THR TYR ARG SEQRES 6 H 209 VAL VAL SER VAL LEU THR VAL LEU HIS GLN ASP TRP LEU SEQRES 7 H 209 ASN GLY LYS GLU TYR LYS CYS LYS VAL SER ASN LYS GLY SEQRES 8 H 209 LEU PRO SER SER ILE GLU LYS THR ILE SER LYS ALA LYS SEQRES 9 H 209 GLY GLN PRO ARG GLU PRO GLN VAL TYR THR PHE PRO PRO SEQRES 10 H 209 GLU GLN GLU GLU MET THR LYS ASN GLN VAL SER LEU ARG SEQRES 11 H 209 CYS LEU VAL LYS GLY PHE TYR PRO SER ASP ILE ALA VAL SEQRES 12 H 209 GLU TRP GLU SER ASN GLY GLN PRO GLU ASN ASN TYR LYS SEQRES 13 H 209 THR THR LYS PRO VAL LEU ASP SER ASP GLY SER PHE ARG SEQRES 14 H 209 LEU GLU SER ARG LEU THR VAL ASP LYS SER ARG TRP GLN SEQRES 15 H 209 GLU GLY ASN VAL PHE SER CYS SER VAL MET HIS GLU ALA SEQRES 16 H 209 CYS SER TYR HIS LEU CYS LYS SER LEU SER LEU SER LEU SEQRES 17 H 209 GLY SEQRES 1 A 267 ALA GLU SER HIS LEU SER LEU LEU TYR HIS LEU THR ALA SEQRES 2 A 267 VAL SER SER PRO ALA PRO GLY THR PRO ALA PHE TRP VAL SEQRES 3 A 267 SER GLY TRP LEU GLY PRO GLN GLN TYR LEU SER TYR ASN SEQRES 4 A 267 SER LEU ARG GLY GLU ALA GLU PRO CYS GLY ALA TRP VAL SEQRES 5 A 267 TRP GLU ASN GLN VAL SER TRP TYR TRP GLU LYS GLU THR SEQRES 6 A 267 THR ASP LEU ARG ILE LYS GLU LYS LEU PHE LEU GLU ALA SEQRES 7 A 267 PHE LYS ALA LEU GLY GLY LYS GLY PRO TYR THR LEU GLN SEQRES 8 A 267 GLY LEU LEU GLY CYS GLU LEU GLY PRO ASP ASN THR SER SEQRES 9 A 267 VAL PRO THR ALA LYS PHE ALA LEU ASN GLY GLU GLU PHE SEQRES 10 A 267 MET ASN PHE ASP LEU LYS GLN GLY THR TRP GLY GLY ASP SEQRES 11 A 267 TRP PRO GLU ALA LEU ALA ILE SER GLN ARG TRP GLN GLN SEQRES 12 A 267 GLN ASP LYS ALA ALA ASN LYS GLU LEU THR PHE LEU LEU SEQRES 13 A 267 PHE SER CYS PRO HIS ARG LEU ARG GLU HIS LEU GLU ARG SEQRES 14 A 267 GLY ARG GLY ASN LEU GLU TRP LYS GLU PRO PRO SER MET SEQRES 15 A 267 ARG LEU LYS ALA ARG PRO SER SER PRO GLY PHE SER VAL SEQRES 16 A 267 LEU THR CYS SER ALA PHE SER PHE TYR PRO PRO GLU LEU SEQRES 17 A 267 GLN LEU ARG PHE LEU ARG ASN GLY LEU ALA ALA GLY THR SEQRES 18 A 267 GLY GLN GLY ASP PHE GLY PRO ASN SER ASP GLY SER PHE SEQRES 19 A 267 HIS ALA SER SER SER LEU THR VAL LYS SER GLY ASP GLU SEQRES 20 A 267 HIS HIS TYR CYS CYS ILE VAL GLN HIS ALA GLY LEU ALA SEQRES 21 A 267 GLN PRO LEU ARG VAL GLU LEU SEQRES 1 B 99 ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG HIS SEQRES 2 B 99 PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS TYR SEQRES 3 B 99 VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP LEU SEQRES 4 B 99 LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SER SEQRES 5 B 99 ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU LEU SEQRES 6 B 99 TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU TYR SEQRES 7 B 99 ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO LYS SEQRES 8 B 99 ILE VAL LYS TRP ASP ARG ASP MET HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET MAN C 4 11 HET NAG C 5 14 HET MAN C 6 11 HET NAG C 7 14 HET FUL C 8 10 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM FUL BETA-L-FUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN FUL BETA-L-FUCOSE; 6-DEOXY-BETA-L-GALACTOPYRANOSE; L- HETSYN 2 FUL FUCOSE; FUCOSE; 6-DEOXY-BETA-L-GALACTOSE FORMUL 4 NAG 4(C8 H15 N O6) FORMUL 4 BMA C6 H12 O6 FORMUL 4 MAN 2(C6 H12 O6) FORMUL 4 FUL C6 H12 O5 FORMUL 5 HOH *33(H2 O) HELIX 1 AA1 LYS H 246 MET H 252 1 7 HELIX 2 AA2 LEU H 309 ASN H 315 1 7 HELIX 3 AA3 LYS H 414 GLU H 419 1 6 HELIX 4 AA4 CYS H 432 LEU H 436 5 5 HELIX 5 AA5 GLY A 49 GLU A 54 5 6 HELIX 6 AA6 TRP A 59 ALA A 81 1 23 HELIX 7 AA7 TRP A 131 GLN A 143 1 13 HELIX 8 AA8 LYS A 146 PHE A 157 1 12 HELIX 9 AA9 PHE A 157 GLY A 170 1 14 HELIX 10 AB1 ASP A 246 HIS A 248 5 3 SHEET 1 AA1 4 SER H 239 PHE H 243 0 SHEET 2 AA1 4 GLU H 258 VAL H 266 -1 O VAL H 262 N PHE H 241 SHEET 3 AA1 4 TYR H 300 THR H 307 -1 O SER H 304 N CYS H 261 SHEET 4 AA1 4 LYS H 288 THR H 289 -1 N LYS H 288 O VAL H 305 SHEET 1 AA2 4 SER H 239 PHE H 243 0 SHEET 2 AA2 4 GLU H 258 VAL H 266 -1 O VAL H 262 N PHE H 241 SHEET 3 AA2 4 TYR H 300 THR H 307 -1 O SER H 304 N CYS H 261 SHEET 4 AA2 4 GLU H 293 GLU H 294 -1 N GLU H 293 O ARG H 301 SHEET 1 AA3 4 VAL H 282 VAL H 284 0 SHEET 2 AA3 4 GLN H 274 VAL H 279 -1 N VAL H 279 O VAL H 282 SHEET 3 AA3 4 GLU H 318 SER H 324 -1 O LYS H 322 N ASN H 276 SHEET 4 AA3 4 ILE H 332 SER H 337 -1 O ILE H 336 N TYR H 319 SHEET 1 AA4 4 GLN H 347 PHE H 351 0 SHEET 2 AA4 4 GLN H 362 PHE H 372 -1 O LYS H 370 N GLN H 347 SHEET 3 AA4 4 PHE H 404 ASP H 413 -1 O PHE H 404 N PHE H 372 SHEET 4 AA4 4 TYR H 391 THR H 393 -1 N LYS H 392 O ARG H 409 SHEET 1 AA5 4 GLN H 347 PHE H 351 0 SHEET 2 AA5 4 GLN H 362 PHE H 372 -1 O LYS H 370 N GLN H 347 SHEET 3 AA5 4 PHE H 404 ASP H 413 -1 O PHE H 404 N PHE H 372 SHEET 4 AA5 4 VAL H 397 LEU H 398 -1 N VAL H 397 O ARG H 405 SHEET 1 AA6 3 GLN H 386 PRO H 387 0 SHEET 2 AA6 3 ALA H 378 SER H 383 -1 N SER H 383 O GLN H 386 SHEET 3 AA6 3 PHE H 423 MET H 428 -1 O MET H 428 N ALA H 378 SHEET 1 AA7 8 GLU A 46 PRO A 47 0 SHEET 2 AA7 8 GLN A 33 ASN A 39 -1 N SER A 37 O GLU A 46 SHEET 3 AA7 8 PHE A 24 LEU A 30 -1 N VAL A 26 O TYR A 38 SHEET 4 AA7 8 SER A 6 VAL A 14 -1 N HIS A 10 O SER A 27 SHEET 5 AA7 8 THR A 89 GLY A 99 -1 O LEU A 94 N TYR A 9 SHEET 6 AA7 8 THR A 103 LEU A 112 -1 O THR A 103 N GLY A 99 SHEET 7 AA7 8 GLU A 115 PHE A 120 -1 O MET A 118 N PHE A 110 SHEET 8 AA7 8 TRP A 127 GLY A 129 -1 O GLY A 128 N ASN A 119 SHEET 1 AA8 4 SER A 181 PRO A 188 0 SHEET 2 AA8 4 PHE A 193 PHE A 203 -1 O SER A 199 N ARG A 183 SHEET 3 AA8 4 PHE A 234 LYS A 243 -1 O VAL A 242 N SER A 194 SHEET 4 AA8 4 PHE A 226 PRO A 228 -1 N GLY A 227 O HIS A 235 SHEET 1 AA9 4 LEU A 217 GLY A 220 0 SHEET 2 AA9 4 LEU A 208 ARG A 214 -1 N PHE A 212 O GLY A 220 SHEET 3 AA9 4 TYR A 250 HIS A 256 -1 O ILE A 253 N ARG A 211 SHEET 4 AA9 4 LEU A 263 VAL A 265 -1 O VAL A 265 N CYS A 252 SHEET 1 AB1 4 LYS B 6 SER B 11 0 SHEET 2 AB1 4 ASN B 21 PHE B 30 -1 O TYR B 26 N GLN B 8 SHEET 3 AB1 4 PHE B 62 PHE B 70 -1 O TYR B 66 N CYS B 25 SHEET 4 AB1 4 GLU B 50 HIS B 51 -1 N GLU B 50 O TYR B 67 SHEET 1 AB2 4 LYS B 6 SER B 11 0 SHEET 2 AB2 4 ASN B 21 PHE B 30 -1 O TYR B 26 N GLN B 8 SHEET 3 AB2 4 PHE B 62 PHE B 70 -1 O TYR B 66 N CYS B 25 SHEET 4 AB2 4 SER B 55 PHE B 56 -1 N SER B 55 O TYR B 63 SHEET 1 AB3 4 GLU B 44 ARG B 45 0 SHEET 2 AB3 4 GLU B 36 LYS B 41 -1 N LYS B 41 O GLU B 44 SHEET 3 AB3 4 TYR B 78 ASN B 83 -1 O ARG B 81 N ASP B 38 SHEET 4 AB3 4 LYS B 91 LYS B 94 -1 O VAL B 93 N CYS B 80 SSBOND 1 CYS H 261 CYS H 321 1555 1555 2.03 SSBOND 2 CYS H 367 CYS H 425 1555 1555 2.02 SSBOND 3 CYS H 432 CYS H 437 1555 1555 2.07 SSBOND 4 CYS A 96 CYS A 159 1555 1555 2.07 SSBOND 5 CYS A 198 CYS A 252 1555 1555 2.01 SSBOND 6 CYS B 25 CYS B 80 1555 1555 2.02 LINK ND2 ASN H 297 C1 NAG C 1 1555 1555 1.44 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.45 LINK O6 NAG C 1 C1 FUL C 8 1555 1555 1.36 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.43 LINK O3 BMA C 3 C1 MAN C 4 1555 1555 1.44 LINK O6 BMA C 3 C1 MAN C 6 1555 1555 1.43 LINK O2 MAN C 4 C1 NAG C 5 1555 1555 1.44 LINK O2 MAN C 6 C1 NAG C 7 1555 1555 1.44 CISPEP 1 TYR H 373 PRO H 374 0 -6.08 CISPEP 2 LEU H 444 GLY H 445 0 2.85 CISPEP 3 TYR A 204 PRO A 205 0 -3.20 CISPEP 4 HIS B 31 PRO B 32 0 1.37 CRYST1 68.284 122.598 178.456 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014645 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008157 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005604 0.00000